1569263-06-4
1569263-06-4
Chemical Structure
Rinucumab
Synonym(s): REGN2176
- CAS No.: 1569263-06-4
- Formula:N/A
- Molecular Weight:(145.5 kDa)
IUPAC Name: 6-amino-4-chloro-5-iodonicotinonitrile
SMILES: [Rinucumab]
Biological Activity: Rinucumab (REGN 2176) is an anti-PDGFR-β antibody. Rinucumab is used for research on neovascular age-related macular degeneration[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Rinucumab | 99.9% | Rinucumab (REGN 2176) is an anti-PDGFR-β antibody. Rinucumab is used for research on neovascular age-related macular degeneration. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Dunn EN, et al. An Overview of the Fovista and Rinucumab Trials and the Fate of Anti-PDGF Medications. Ophthalmic Surg Lasers Imaging Retina. 2017 Feb 1;48(2):100-104. [Content Brief]
- [2]. Megan Cully, et al. Deal watch: Novartis eyes vision-enhancing therapy for macular degeneration. Nat Rev Drug Discov. 2014 Jul;13(7):487. [Content Brief]
